BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 27566024)

  • 1. Sentinel node biopsy in patients with primary cutaneous melanoma of any thickness: A cost-effectiveness analysis.
    Serra-Arbeloa P; Rabines-Juárez ÁO; Álvarez-Ruiz MS; Guillén-Grima F
    Surg Oncol; 2016 Sep; 25(3):205-11. PubMed ID: 27566024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cost-effectiveness of sentinel node biopsy in patients with intermediate thickness primary cutaneous melanoma.
    Morton RL; Howard K; Thompson JF
    Ann Surg Oncol; 2009 Apr; 16(4):929-40. PubMed ID: 18825458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of sentinel lymph node biopsy for solitary dermal melanomas.
    Hu Y; Shah P; Stukenborg GJ; Slingluff CL
    J Surg Oncol; 2015 Jun; 111(7):800-7. PubMed ID: 25712273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interval between primary melanoma excision and sentinel node biopsy is not associated with survival in sentinel node positive patients - An EORTC Melanoma Group study.
    Oude Ophuis CM; Verhoef C; Rutkowski P; Powell BW; van der Hage JA; van Leeuwen PA; Voit CA; Testori A; Robert C; Hoekstra HJ; Grünhagen DJ; Eggermont AM; van Akkooi AC
    Eur J Surg Oncol; 2016 Dec; 42(12):1906-1913. PubMed ID: 27266406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma.
    Doubrovsky A; De Wilt JH; Scolyer RA; McCarthy WH; Thompson JF
    Ann Surg Oncol; 2004 Sep; 11(9):829-36. PubMed ID: 15313732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel-node biopsy or nodal observation in melanoma.
    Morton DL; Thompson JF; Cochran AJ; Mozzillo N; Elashoff R; Essner R; Nieweg OE; Roses DF; Hoekstra HJ; Karakousis CP; Reintgen DS; Coventry BJ; Glass EC; Wang HJ;
    N Engl J Med; 2006 Sep; 355(13):1307-17. PubMed ID: 17005948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel lymph node biopsy in patients with thin melanoma: occurrence of nodal metastases and its prognostic value.
    Vermeeren L; Van der Ent F; Sastrowijoto P; Hulsewé K
    Eur J Dermatol; 2010; 20(1):30-4. PubMed ID: 19889594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of Life Following Sentinel Node Biopsy for Primary Cutaneous Melanoma: Health Economic Implications.
    Morton RL; Tran A; Vessey JY; Rowbotham N; Winstanley J; Shannon K; Spillane AJ; Stretch J; Thompson JF; Saw RP
    Ann Surg Oncol; 2017 Aug; 24(8):2071-2079. PubMed ID: 28321690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling the cost-effectiveness of sentinel lymph node mapping and adjuvant interferon treatment for stage II melanoma.
    Wilson LS; Reyes CM; Lu C; Lu M; Yen C
    Melanoma Res; 2002 Dec; 12(6):607-17. PubMed ID: 12459651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome following sentinel node biopsy plus wide local excision versus wide local excision only for primary cutaneous melanoma: analysis of 5840 patients treated at a single institution.
    van der Ploeg AP; Haydu LE; Spillane AJ; Quinn MJ; Saw RP; Shannon KF; Stretch JR; Uren RF; Scolyer RA; Thompson JF
    Ann Surg; 2014 Jul; 260(1):149-57. PubMed ID: 24633018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of sentinel node biopsy and pathological ultrastaging in patients with early-stage cervical cancer.
    Brar H; Hogen L; Covens A
    Cancer; 2017 May; 123(10):1751-1759. PubMed ID: 28117888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel lymph node biopsy is prognostic but not therapeutic for thick melanoma.
    Kachare SD; Singla P; Vohra NA; Zervos EE; Wong JH; Fitzgerald TL
    Surgery; 2015 Sep; 158(3):662-8. PubMed ID: 26096561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
    Nowecki ZI; Rutkowski P; Michej W
    Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incomplete sentinel node biopsy is not clearly related to survival or regional recurrence in cutaneous melanoma patients.
    Lee NC; Spillane AJ; Pang TC; Haydu LE; Uren RF
    Ann Surg Oncol; 2012 Jan; 19(1):280-6. PubMed ID: 21833669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel node biopsy in thin and thick melanoma.
    Mozzillo N; Pennacchioli E; Gandini S; Caracò C; Crispo A; Botti G; Lastoria S; Barberis M; Verrecchia F; Testori A
    Ann Surg Oncol; 2013 Aug; 20(8):2780-6. PubMed ID: 23720068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
    Nahabedian MY; Tufaro AP; Manson PN
    Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of sentinel lymph node biopsy on survival for intermediate-thickness melanoma.
    Kachare SD; Brinkley J; Wong JH; Vohra NA; Zervos EE; Fitzgerald TL
    Ann Surg Oncol; 2014 Oct; 21(11):3377-85. PubMed ID: 25063010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can sentinel node biopsy be safely omitted in thin melanoma? Risk factor analysis of 1272 multicenter prospective cases.
    Piazzalunga D; Ceresoli M; Allievi N; Ribero S; Quaglino P; Di Lorenzo S; Corradino B; Campana LG; Mocellin S; Rossi CR;
    Eur J Surg Oncol; 2019 May; 45(5):820-824. PubMed ID: 30527782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas.
    Wat H; Senthilselvan A; Salopek TG
    J Am Acad Dermatol; 2016 Jan; 74(1):94-101. PubMed ID: 26542815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.